Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
A multicenter clinical trial is evaluating how social and genetic factors influence outcomes among adolescent and young adult survivors of H…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL [Phase 2]
An ongoing Phase 2 trial comparing AVD with low-dose nivolumab versus PET-adapted BEACOPP-like therapy in advanced classical Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Brentuximab Vedotin in Early Stage Hodgkin Lymphoma [Phase 3]
A Phase 3 clinical trial evaluating Brentuximab vedotin in early-stage Hodgkin lymphoma is currently recruiting. The sponsor listed is Unive…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating carmustine with and without ethanol in subjects with lymphoma, including Hodgkin and non-Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant [Phase 1]
Phase 1 clinical trial evaluating CMV-MVA Triplex Vaccine to enhance CMV-specific immunity and prevent CMV viremia in patients undergoing ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2026-03-27Clinical Trial Update: Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies [Phase 1]
Phase 1 basket trial update for cord blood-derived NK cells engineered with IL-15 and TGFBR2 knockout, for relapsed/refractory lymphoid mali…
-
CLINICAL_TRIALS other · 2026-03-23Clinical Trial Update: Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study [Phase 2]
Clinical trial HALTAging-1 is a Phase 2 study targeting aging in survivors of blood cancers; the trial is not yet recruiting.
-
EMA approval · 2026-03-20EMA Authorised: Adcetris (Brentuximab vedotin) — Takeda Pharma A/S
EMA authorised Adcetris (brentuximab vedotin) for Hodgkin lymphoma and non-Hodgkin lymphoma, with Takeda Pharma A/S as the marketing authori…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Improving Exercise Capacity With a Tailored Physical Activity Intervention [NA]
This clinical trial update indicates Wake Forest University Health Sciences is recruiting for a tailored physical activity intervention aime…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma [Phase 4]
Phase 4 clinical trial CCCG-HD-2018 for newly diagnosed Hodgkin lymphoma in children and adolescents. The study is currently active but not …
-
EMA approval · 2026-03-18EMA Authorised: Opdivo (nivolumab) — Bristol-Myers Squibb Pharma EEIG
EMA authorised Opdivo (nivolumab) for multiple cancer indications, including melanoma, Hodgkin lymphoma, renal cell carcinoma, non-small cel…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating ctDNA-guided therapy for adults with relapsed or refractory Hodgkin lymphoma; the study is currently not…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) [Phase 1, Phase 2]
A pediatric Phase 1/2 study of pembrolizumab (Keytruda) in children with advanced solid tumors or lymphoma is currently recruiting. The tria…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL [Phase 2]
A Phase II trial is evaluating a four-drug combination (mosunetuzumab, polatuzumab vedotin, tafasitamab, and lenalidomide) in relapsed B-cel…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders [Phase 2]
Phase 2 clinical trial evaluating cord blood transplant in children and young adults with blood cancers and select non-malignant disorders; …
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating CMV-MVA Triplex vaccination in HLA-matched related stem cell donors to prevent cytomegalovirus infection i…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 1, Phase 2]
An ongoing phase 1/2 clinical trial is evaluating the combination of nivolumab and ruxolitinib for relapsed or refractory classical Hodgkin …
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders [NA]
This update reports the completed status of a trial assessing bone marrow and kidney transplant for patients with chronic kidney disease and…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant [Phase 1]
A Phase 1 study evaluating the use of melphalan in lymphoma patients undergoing autologous hematopoietic cell transplantation.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission [Phase 2]
Phase 2 clinical trial of tislelizumab with gemcitabine and cisplatin for relapsed/refractory Hodgkin lymphoma, followed by tislelizumab con…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
A clinical trial update notes a study evaluating chemotherapy-induced cognitive disorders in patients treated for hematological malignancies…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial investigating personalized reduction of chemotherapy intensity in advanced Hodgkin lymphoma guided by ctDNA measureme…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: CD45BE-HSPC + CART-45 Cells [Phase 1]
Phase 1 study evaluating CD45BE-HSPC with CART-45 cells is not yet recruiting and targets B-cell non-Hodgkin lymphoma and Richter transforma…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update evaluating TCRαβ-depleted progenitor cell graft with added memory T-cell donor lymphocyte infusion and selecti…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
This clinical trial update indicates active recruitment for a longitudinal study on sexual and reproductive health in women with breast canc…